Sectors
BHVN
Biohaven Ltd.
15.64
5 x 15.55
1 x 15.56
bid
ask
+
0.23
1.49%
03:10 PM
timesize
| Ytd | 38.53% | |
| 1y | 1.62% |
15.18
day range
15.79
7.48
52 week range
18.57
| Open | 15.46 | Prev Close | 15.41 | Low | 15.18 | High | 15.79 | Mkt Cap | 2.36B |
| Vol | 1.40M | Avg Vol | 3.02M | EPS | -4.55 | P/E | N/A | Forward P/E | -7.75 |
| Beta | 1.26 | Short Ratio | 9.83 | Inst. Own | 96.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 14.77 | 200-d Avg | 11.53 | 1yr Est | 21.73 |
| Income Statement | |||
| Operating Expenses | 124.90M | ||
| Research and Development Expense | 100.81M | ||
| Selling, General and Administrative Expense | 24.09M | ||
| Operating Income | -124.90M | ||
| Income Tax Expense | 391.00K | ||
| Net Income | -137.31M | ||
| Net Income Common Stock | -137.31M | ||
| Net Income Common Stock (USD) | -137.31M | ||
| Consolidated Income | -137.31M | ||
| Earnings per Basic Share | -0.91 | ||
| Earnings per Basic Share (USD) | -0.91 | ||
| Earnings per Diluted Share | -0.91 | ||
| Earning Before Interest & Taxes (EBIT) | -136.92M | ||
| Earning Before Interest & Taxes (USD) | -136.92M | ||
| Weighted Average Shares | 150.64M | ||
| Weighted Average Shares Diluted | 150.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 238.03M | ||
| Cash and Equivalents (USD) | 238.03M | ||
| Investments | 29.83M | ||
| Investments Current | 29.83M | ||
| Current Assets | 296.56M | ||
| Property, Plant & Equipment Net | 15.09M | ||
| Total Assets | 370.74M | ||
| Total Debt | 292.37M | ||
| Current Liabilities | 62.66M | ||
| Debt Non-Current | 292.37M | ||
| Total Liabilities | 358.52M | ||
| Accumulated Retained Earnings (Deficit) | -2.35B | ||
| Accumulated Other Comprehensive Income | 5.38M | ||
| Shareholders Equity | 12.22M | ||
| Shareholders Equity (USD) | 12.22M | ||
| Assets Non-Current | 74.18M | ||
| Total Debt (USD) | 292.37M | ||
| Goodwill and Intangible Assets | 19.79M | ||
| Liabilities Non-Current | 295.86M | ||
| Trade and Non-Trade Payables | 12.11M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.26M | ||
| Net Cash Flow from Financing | 3.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.48M | ||
| Capital Expenditure | -454.00K | ||
| Issuance (Purchase) of Equity Shares | 3.80M | ||
| Net Cash Flow from Investing | 44.82M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 45.28M | ||
| Net Cash Flow from Operations | -85.10M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 19.16M | ||